With a population of over 1.3 billion, China is poised for continued growth in the life sciences sector. There are sever...
Singapore: China's State Intellectual Property Office (SIPO) has yanked the patent for Gilead Sciences popular HIV and h...
Singapore: Innovent Biologics, a company dedicated to the development and manufacturing of monoclonal antibodies, is con...
Singapore: Heartbeat Experts, the global leader in stakeholder management solutions for the life sciences industry has a...
Singapore: Gene expression profiling can bring significant improvements to disease profiling and diagnoses based on gene...
Singapore: The National Health and Family Planning Commission of China has notified WHO of an additional 10 laboratory-...
DelMar Pharmaceuticals was founded in 2010 to rapidly develop and commercialize proven cancer therapies in new indicatio...
Singapore: HUYA Bioscience International has entered into a collaborative partnership with Shanghai Zhangjiang Biotech a...
Singapore: China's BGI Shenzhen along with Reproductive and Genetic Hospital Citic-Xiangya has successfully applied Next...
Singapore: Executives from biotech and pharmaceutical companies, along with investment firms from North America, Europe ...
Singapore: The epilepsy therapeutics market value in the Asia-Pacific (APAC) region, Australia, China, India and Japan, ...
Singapore: Global Logistic Properties (GLP), one of the world's leading providers of modern logistics facilities, with a...
Singapore: Beijing Genomics Institute (BGI), the world's largest genomics organization, has successfully developed a new...
North China Pharmaceutical Group (NCPC) is a nationwide provider of bulk pharmaceuticals in China, including antibiotics...
Singapore: The head of the Chinese pharmaceutical company Hanwei Yaoye has been arrested for allegedly helping illegal b...
Singapore: China based Concord Medical Services, a hospital management solution provider has signed a multi-year strateg...
Singapore: China based Ascletis has received Taiwan Food and Drug Administration (TFDA) approval to start phase II clini...
Sinopharm, a dominant name in the distribution of pharmaceutical and healthcare products in China, continues to grab a...
